ϩ /Ca 2ϩ exchanger (NCX1) transgene was switched on when doxycycline was removed from the feed at 5 wk. At 8 to 10 wk, NCX1 expression in induced (Ind) mouse hearts was 2.5-fold higher but protein levels of sarco(endo)plasmic reticulum Ca 2ϩ -ATPase, ␣1-and ␣2-subunits of Na ϩ -K ϩ -ATPase, phospholamban, ryanodine receptor, calsequestrin, and unphosphorylated and phosphorylated phospholemman were unchanged compared with wild-type (WT) or noninduced (non-Ind) hearts. There was no cellular hypertrophy since WT, non-Ind, and Ind myocytes had similar whole cell membrane capacitance. In Ind myocytes, NCX1 current amplitude was ϳ42% higher, L-type Ca 2ϩ current amplitude was unchanged, and action potential duration was prolonged compared with WT or non-Ind myocytes. Contraction and intracellular Ca 2ϩ concentration ([Ca 2ϩ ]i) transient amplitudes in Ind myocytes were lower at 0.6, not different at 1.8, and higher at 5.0 mM extracellular Ca 2ϩ concentration ([Ca 2ϩ ]o) compared with WT or non-Ind myocytes. Despite similar Ca 2ϩ current amplitude and sarcoplasmic reticulum (SR) Ca 2ϩ uptake, SR Ca 2ϩ content at 5.0 mM [Ca 2ϩ ]o was significantly higher in Ind compared with non-Ind myocytes, indicating that NCX1 directly contributed to SR Ca 2ϩ loading. Echocardiography demonstrated that heart rate, left ventricular mass, ejection fraction, stroke volume, and cardiac output were similar among the three groups of animals. In vivo close-chest catheterization demonstrated similar contractility and relaxation among the three groups of mice, both at baseline and after stimulation with isoproterenol. We conclude that induced expression of NCX1 transgene resulted in altered [Ca 2ϩ ]i homeostasis, myocyte contractility, and action potential morphology. In addition, heart failure did not occur 3 to 5 wk after NCX1 transgene was induced to be expressed at levels found in diseased hearts.
tet-off; excitation-contraction; fura-2; isolated mouse myocytes; electrophysiology; sarcoplasmic reticulum; intracellular Ca 2ϩ concentration CA 2ϩ IONS ARE CENTRALLY INVOLVED in excitation-contraction (EC) in cardiac muscle. Among the many transporters and ion channels involved in Ca 2ϩ fluxes in cardiac myocytes, Na ϩ /Ca 2ϩ exchanger (NCX1) is unique in that it mediates both Ca 2ϩ efflux (forward mode, 3 Na ϩ in and 1 Ca 2ϩ out) and Ca 2ϩ influx (reverse mode, 3 Na ϩ out and 1 Ca 2ϩ in) during an EC cycle (4) . At physiological extracellular Ca 2ϩ concentration ([Ca 2ϩ ] o ) and at rest, it is generally accepted that NCX1 primarily functions in the Ca 2ϩ efflux mode. During systole, when the membrane potential (E m ) exceeds the equilibrium potential of NCX1 (E NaCa ), Ca 2ϩ influx is favored (2, 38) . The extent and duration of Ca 2ϩ influx mediated by NCX1 is species dependent, likely due to differences in intracellular Na ϩ concentration ([Na ϩ ] i ) and action potential morphology among species (31, 38) . For example, in rodent myocytes, the relatively high [Na ϩ ] i (ϳ11 to 12 mM) compared with that present in rabbit myocytes (ϳ4.5 mM) (10, 31) would bias NCX1 to Ca 2ϩ influx mode during the action potential most of the time (13, 38) . Indeed, although NCX1 overexpression in isolated adult rabbit myocytes (by adenovirus-mediated gene transfer) results primarily in impaired myocyte contractility compared with control myocytes (25, 30) , in adult rat myocytes NCX1 overexpression can result in either decreased, no change, or increased contraction and intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) transient amplitudes, depending on prevailing [Ca 2ϩ ] o (45) . Over the last decade, Philipson and his colleagues have made major contributions toward our understanding of NCX1 function in vivo and in vitro by the generation of constitutively expressed NCX1 transgenic (1, 27, 28, 36, 40) and the cardiacspecific NCX1 knock-out (17, (22) (23) (24) mice. During the same period, it became increasingly clear that alterations in NCX1 expression and/or activity are associated with many models of cardiac hypertrophy and heart failure (for review, see Ref. 32) . It remains controversial, however, whether the change in NCX1 expression and/or activity is a beneficial compensatory mechanism in response to contractile dysfunction or detrimental, leading to further deterioration of heart failure. One approach to differentiate between cause and compensatory response is the ability to switch on the expression of the NCX1 transgene concomitantly with the onset of the disease state. The purpose of the present study was to characterize a novel transgenic mouse model in which expression of the rat NCX1 transgene was under the control of a cardiac-specific promoter driving the expression of a tetracycline transactivator (tTA). When doxycycline (Dox) was removed from the feed, expression of NCX1 transgene was induced. Using this novel mouse model, we tested the hypotheses that 1) myocytes with induced NCX1 expression exhibited changes in Ca 2ϩ homeostasis and contractility according to the thermodynamic driving force for the exchanger and 2) moderate NCX1 overexpression, by itself, did not cause contractile failure in vivo.
METHODS

Generation of inducible NCX1 transgenic mouse.
A cardiac-specific and inducible controlled vector composed of a modified mouse ␣-myosin heavy chain (MHC) minimal promoter fused with nucleotide binding sites for tTA (TREMHC) was used to provide robust expression when turned on in the absence of Dox and minimal leakage when turned off in the presence of Dox (29) . Sequence-verified rat NCX1 gene (45) was cloned into TREMHC vector and microinjected into the nuclei of FVB mice for transgenic mice production. Eleven transgenic founders (7 males and 4 females) were generated. To quantify the number of transgenes inserted into the genome, genomic DNA from mouse-tail was isolated using the Qiagen DNAeasy kit. Genomic DNA (100 ng) was used for real-time PCR using NCX1-specific primer set (forward, CCCAATGTTTCAATGGGATT; and reverse, AGATGGGTCTTGGGGTTC) and GAPDH set (forward, AACGACCCCTTCATTGAC; and reverse, TCCACGACATACT-CAGCAC). NCX1-specific primers were conserved between mouse and rat NCX1 and detected rat and mouse NCX1 gene with equal efficiency (data not shown). Real-time PCR was performed in a 20-l reaction (100 ng of genomic DNA; 500 nM each primer; 1X SYBRE Green Master Mix). Each experimental sample was performed in triplicate. The ⌬CT method was used to quantify the results, which are presented as relative fold changes to the GAPDH gene. Each primer set was designed to assume a melting temperature of 60°C and 50% GC content.
Since expression of the transgene required the presence of Doxresponsive transcription factor tTA, all founder mice were healthy and fertile. To determine phenotype, transgenic founders were crossed to the cardiac tTA transgenic mice in FVB background (MHC-tTA). Littermates that were heterozygous for tTA but negative for NCX1 transgene were used as wild-type (WT) controls. To prevent NCX1 expression, Dox (300 mg/kg mouse diet; Bio-Serv) was administered to all pregnant mothers and offsprings of WT and NCX1 transgenic groups. To induce NCX1 expression in adult mice, Dox was removed from the feed at 5 wk of age and mice were studied 3 to 5 wk later. The MHC-tTA mouse line expressed tTA at very low levels. Expression of tTA in WT mice did not affect mouse heart weight and function up to 12 wk. Similarly, Dox alone did not affect WT mouse heart size or function (data not shown).
Mice were housed and fed on a 12-h:12-h light-dark cycle at the Thomas Jefferson University Animal Facility and were supervised by veterinary staff members. Standard care was provided to all mice used for experiments. All protocols applied to the mice in this study were approved and supervised by the Institutional Animal Care and Use Committee at Thomas Jefferson University.
Echocardiographic and hemodynamic analysis of cardiac function. Transthoracic two-dimensional echocardiography (TTE) was performed in anesthetized (2% inhaled isoflurane) WT, induced (Ind), and noninduced (non-Ind) mice with a 12-MHz probe (20) . TTE in M mode was carried out in the parasternal short-axis to assess left ventricular (LV) diameter and function. For in vivo hemodynamic measurements, a 1.4 French micromanometer-tipped catheter (SPR-671; Millar Instruments) was inserted into the right carotid artery and then advanced into the LV of lightly anesthetized (tribromoethanolamylene hydrate, Avertin; 2.5% wt/vol, 8 l/g ip) mice with spontaneous respirations. Hemodynamic parameters including heart rate (beats per min Ϫ1 ), LV end-diastolic pressure, and maximal first time derivative of LV pressure rise (ϩdP/dt) and fall (ϪdP/dt) were recorded in closed-chest mode, both at baseline and in response to progressive doses of isoproterenol (0.1, 0.5, 1, 5, and 10 ng).
Isolation of adult murine cardiac myocytes. Cardiac myocytes were isolated from the septum and LV free wall of WT, Ind, and non-Ind mice (ϳ27 g) according to the protocol of Zhou et al. (47) and modified by our laboratory (35, 37) . Briefly, mice were heparinized (1,500 u/kg ip) and anesthetized (pentobarbital sodium, 50 mg/kg ip). The heart was excised, mounted on a steel cannula, and retrograde perfused (100 cmH2O, 37°C) with Ca 2ϩ -free bicarbonate buffer followed by enzymatic digestion (collagenases B and D, protease XIV). Isolated myocytes were plated on laminin-coated glass coverslips in a petri dish, and the Ca 2ϩ concentration of the buffer was progressively increased from 0.05 to 0.125 to 0.25 to 0.5 mM in three steps (10-min interval each). The 0.5 mM Ca 2ϩ buffer was then aspirated and replaced with minimal essential medium (MEM; Sigma M1018) containing 1.2 mM Ca 2ϩ , 2.5% fetal bovine serum (FBS), and antibiotics (1% penicillin-streptomycin). The pH was adjusted to 7.0 in 4% CO 2 by the addition of NaHCO3 (0.57 g/l). After 1 h (4% CO 2, 37°), media was replaced with FBS-free MEM containing 0.1 mg/ml bovine serum albumin and antibiotics. Myocytes were used within 2 to 8 h of isolation.
Myocyte shortening measurements. Myocytes adherent to coverslips were bathed in 0.6 ml of air-and temperature-equilibrated (37°C), HEPES-buffered (20 mM, pH 7.4) medium 199 containing 0.6, 1.8, or 5.0 mM [Ca 2ϩ ]o. Measurements of myocyte contraction (1 Hz) were performed as previously described (35, 37) .
[ ]i transient analyses were performed as previously described (35, 37) . Na ϩ /Ca 2ϩ exchange current measurements. Whole cell patchclamp recordings were performed at 30°C as previously described (35, 37, 42, 43 (35, 37, 42) . Verapamil (1 M), ouabain (1 mM), and niflumic acid (10 M) were used to block L-type Ca 2ϩ currents, Na ϩ -K ϩ -ATPase currents, and Cl Ϫ currents, respectively. The myocyte was held at the calculated ENaCa of Ϫ73 mV for at least 5 min before current was elicited with a descending-ascending voltage ramp (from ϩ100 to Ϫ120 and back to ϩ100 mV, 500 mV/s). INaCa, defined as the difference current in the absence and presence of NiCl2 (1 mM), was normalized to whole cell capacitance (Cm) before comparisons. 4 with NaOH). Before myocyte stimulation was started, holding potential was changed from Ϫ70 to Ϫ40 mV to inactivate fast inward Na ϩ current. To ensure steady-state sarcoplasmic reticulum (SR) Ca 2ϩ loading, six conditioning pulses (from Ϫ40 to 0 mV, 300 ms, 1 Hz) were delivered before arrival of each test pulse (from Ϫ30 to ϩ40 mV, 10-mV increments, 400 ms). After the last test pulse at ϩ40 mV, the myocyte was held at Ϫ40 mV for 1 s before being returned to holding potential of Ϫ70 mV. Leak-subtracted inward currents were used in analysis for L-type Ca 2ϩ current (ICa) amplitudes and inactivation kinetics. ICa was normalized to Cm before comparison among WT, Ind, and non-Ind myocytes.
ICa inactivation kinetics were determined by least-square fitting of a two-exponential function [A1exp(-t/1) ϩ A2exp(-t/2) ϩ C], where t is time; 1 and 2 are the fast and slow inactivation time constants, respectively; and A1, A2, and C are arbitrary constants. ICa data for voltage dependence of steady-state activation were fitted to Boltzmann distribution of the form I/I max ϭ 1/[1 ϩ exp(Vh Ϫ V)/k] where I and I max are current and maximal current, respectively; V was the test activating potential; V h was the test potential eliciting one-half I max; and k was the slope factor. Similarly, voltage dependence of steady-state inactivation of I Ca was determined by a voltage prepulse protocol (43) , and I Ca data were fitted to a Boltzmann function of the form
where V is the prepulse potential and I max, Vh, and k have their usual meanings.
Action potential measurements. Action potentials were recorded using current-clamp configuration at 1.5ϫ threshold stimulus and 4-ms duration (37, 46) . Pipette solution consisted of (in mM) 125 KCl, 4 MgCl 2, 0.06 CaCl2, 10 HEPES, 5 K ϩ -EGTA, 3 Na2ATP, and 5 Na 2-creatine phosphate (pH 7.2). External solution consisted of (in mM) 132 NaCl, 5.4 KCl, 1.8 CaCl 2, 1.8 MgCl2, 0.6 NaH2PO4, 7.5 HEPES, 7.5 Na ϩ -HEPES, and 5 glucose (pH 7.4). SR Ca 2ϩ content measurements. SR Ca 2ϩ content was estimated by integrating forward I NaCa induced by caffeine exposure as described previously (35, 37, 41) . The pipette solution consisted of (in mM) 100 Cs ϩ -glutamate, 1 MgCl2, 30 HEPES, and 2.5 MgATP (pH 7.2). The external solution contained (in mM) 130 NaCl, 5 CsCl, 1.2 MgSO 4, 1.2 NaH2PO4, 5 CaCl2, 20 HEPES, and 10 glucose (pH 7.4; 30°C). Holding potential was Ϫ70 mV. At 200 ms after the 11th conditioning pulse (from Ϫ70 to 0 mV, 300 ms, 1 Hz), with Em held at Ϫ70 mV, caffeine (5 mM, 2.4 s) was applied by puffer superfusion. The resulting inward current was digitized at 1 kHz and collected for 5 s. To convert INaCa time integral (coulombs) to moles, charge was divided by Faraday's constant of 96,487 coulombs/equivalent, based on 3 Na ϩ being exchanged for each Ca 2ϩ . SR Ca 2ϩ content was normalized to cell size and given as femtomole per femtofared.
Immunoblotting. Crude membranes from mouse left ventricles were prepared using a two-step centrifugation protocol described previously (34) . For detection of NCX1, sarco(endo)plasmic reticulum Ca 2ϩ -ATPase (SERCA2), calsequestrin, and ␣1-and ␣2-subunits of Na ϩ -K ϩ -ATPase, proteins in crude membranes were subjected to 7.5% SDS-PAGE under nonreducing (10 mM N-ethylmaleimide for NCX1) or reducing (5% ␤-mercaptoethanol for SERCA2, calsequestrin, and Na ϩ -K ϩ -ATPase) conditions. For detection of cardiac ryanodine receptor (RyR2) and phospholamban (PLB), proteins were subjected to 3-8% (Tris-acetate; reducing conditions) and 12% (Trisglycine; both reducing and nonreducing conditions) SDS-PAGE, respectively. Primary antibodies used were as follows: for NCX1, 11-13 polyclonal antibody (1:500; Swant, Bellinzona, Switzerland); for SERCA2, MA3-919 antibody (1:2,500; Affinity BioReagents, Golden, CO); for RyR2, MA3-916 antibody (1:1,000; Affinity BioReagents); for PLB, MA3-922 antibody (1:500; Affinity BioReagents); for calsequestrin, rabbit anti-calsequestrin antibody (1: 2,500; Swant); and polyclonal antibodies against either ␣1-(1:1,000; Upstate USA, Charlottesville, VA) or ␣2-subunit of Na ϩ -K ϩ -ATPase (1:1,200; Upstate USA). Secondary antibodies were donkey antirabbit or sheep anti-mouse IgG (Amersham). For phospholemman (PLM) immunoblotting, proteins in crude membranes were subjected to 12% SDS-PAGE under reducing conditions. Polyclonal C2 antibody (1:10,000) was used to detect the COOH terminus of endogenous mouse PLM (predominantly unphosphorylated form) (33) . Polyclonal CP68 antibody (1:2,000) was used to detect PLM phosphorylated at serine68 (26) . Immunoreactive proteins were detected with enhanced chemiluminescence Western blotting system. Protein band signal intensities were quantitated by scanning autoradiograms of the blots with a phosphorimager.
Statistics. All results are expressed as means Ϯ SE. In all analyses, P Ͻ 0.05 was taken to be statistically significant.
RESULTS
Inducible NCX1 transgenic mouse. Eleven founders (7 males, 4 females) harboring the rat NCX1 transgene were generated. The transgenic mice were all heterozygous. Analysis of mouse genomic DNA showed that founder lines contained transgene copies that are 2 to 37 times above the endogenous mouse NCX1 gene copies (data not shown). We selected a transgenic line with 11 times more NCX1 transgene copies (line B) for expression studies. To control the timing of overexpression, we crossed the NCX1 transgenic founder with homozygous MHC-tTA mice in the presence of Dox. Mice that were heterozygous for both tTA and NCX1 transgenes were used as the experimental (Ind and non-Ind) groups, whereas littermates that were heterozygous for tTA only were used as WT controls.
We chose founder line B because preliminary experiments showed that 3 wk after induction, NCX1 protein levels were ϳ2ϫ that of WT hearts, assuming equal sensitivity of the polyclonal 11-13 antibody to detect rat and mouse NCX1. This magnitude of NCX1 increase in Ind hearts was similar to that found in models of heart failure (32) . Another reason to choose to study a founder line with modest levels of NCX1 transgene expression is that high levels of transgenic expression of even seemingly innocuous proteins such as green fluorescent protein (18) or Cre-recombinase (6) can cause dilated cardiomyopathy.
Both Ind and non-Ind mice had no readily observable altered phenotype in that both body weights and LV mass were similar to those measured in WT mice ( Table 1) . Indexes of cardiac performance, as determined by TTE and in vivo catheterization, were also similar among the three groups of animals ( Table 1) . Contractility responses (ϩdP/dt) to isoproterenol stimulation were similar among the three groups of animals ( Fig. 1 ; group ϫ isoproterenol interaction effect, P Ͻ 0.42). For example, in response to maximal doses of isoproterenol, ϩdP/dt increased by 86.6 Ϯ 18.0%, 107.9 Ϯ 7.9%, and 114.4 Ϯ 20.3% in WT (n ϭ 6), Ind (n ϭ 7), and non-Ind (n ϭ 3) hearts, respectively. Likewise, there were no significant differences in relaxation (ϪdP/dt) in response to maximal doses of isoproterenol in WT (77.7 Ϯ 24.5% increase), Ind (86.9 Ϯ 19.7% increase), and non-Ind (84.7 Ϯ 4.2% increase) mice (group ϫ isoproterenol interaction effect, P Ͻ 0.29).
To quantify the fold increase in NCX1 expression in Ind compared with WT or non-Ind hearts, we evaluated the reactivity of 11-13 antibody (raised against canine NCX1 but epitope is unknown) against the rat NCX1 transgene and native mouse NCX1. Crude LV membranes were prepared from Spraque-Dawley rats and FVB mice (n ϭ 4 each) and subjected to Western blotting. With the assumption of an equal number of NCX1 molecules per milligram of LV membrane between rat and mouse, the signals from 11-13 antibody were 1.70ϫ higher for mouse (2,949 Ϯ 110) than rat (1,732 Ϯ 51 arbitrary units) NCX1 ( Fig. 2 ; P Ͻ 0.0001). With the use of the monoclonal antibody 6H2 raised against the NH 2 terminus of rabbit NCX1, the NCX1 signals from rat and mouse LV membranes were similar (Fig. 2) , providing support for our assumption that NCX1 density was similar between mouse and rat LV membranes. Applying the correction factor of 1.7 suggests that protein levels of NCX1 in Ind hearts were ϳ2.5-fold higher compared with WT or non-Ind hearts ( Fig. 2 and Table 2 ). By contrast, expression of SERCA2, ␣ 1 -and ␣ 2 -subunits of Na ϩ -K ϩ -ATPase, RyR2, PLB, calsequestrin, and both unphosphorylated and phosphorylated forms of PLM was not altered by the induction of NCX1 transgene ( Fig. 2 and Table 2 ). Ind myocytes did not undergo hypertrophy since C m , a measure of cell surface membrane area, was similar among WT (154.8 Ϯ 5.3 pF; n ϭ 24), non-Ind (149.9 Ϯ 7.5 pF; n ϭ 17), and Ind (163.5 Ϯ 9.0 pF; n ϭ 18) myocytes.
Effects of induced NCX1 transgene expression on Na ϩ /Ca 2ϩ exchange activity. Na ϩ /Ca 2ϩ exchange activity measured as NCX1 current (I NaCa ) in all three groups of myocytes increased as voltage became more positive ( Fig. 3 ; voltage effect, P Ͻ 0.0001). I NaCa was significantly (group effect, P Ͻ 0.0001) increased in Ind myocytes compared with WT or non-Ind myocytes (Fig. 3) . Our conditions were biased toward measuring outward (3 Na ϩ out and 1 Ca 2ϩ in) rather than inward (3 Na ϩ in and 1 Ca 2ϩ out) I NaCa . This accounts for the significant group ϫ voltage interaction effects (P Ͻ 0.0001), indicating that differences in I NaCa magnitude between Ind and WT or non-Ind myocytes increased with positive voltages. At ϩ100 mV, I NaCa was ϳ40% higher in Ind compared with WT or non-Ind myocytes. There were no differences in I NaCa between WT and non-Ind myocytes (group effect, P Ͻ 0.48; group ϫ voltage interaction effect, P Ͻ 0.23). Fig. 2 . Induced expression of Na ϩ /Ca 2ϩ exchanger transgene does not change the expression of selected proteins involved in excitation-contraction coupling. Top: crude membranes were prepared from wild-type (WT), induced, and noninduced (non-Ind) mouse left ventricle (LV) and subjected to SDS-PAGE followed by Western blot analysis. Primary antibodies (see METHODS) were used to detect cardiac Na ϩ /Ca 2ϩ exchanger (NCX1), ␣1 (alpha1)-and ␣2 (alpha2)-subunits of Na ϩ -K ϩ -ATPase, sarco(endo)plasmic reticulum Ca 2ϩ -ATPase (SERCA2), unphosphorylated phospholemman (C2), phospholemman phosphorylated at serine68 (Cp68), cardiac ryanodine receptor (RyR2), high and low molecular weight phospholamban (PLBH and PLBL, respectively), and calsequestrin (CLSQ). PLBH was detected under nonreducing conditions (only 1 band at ϳ25 kDa), and PLBL was detected under reducing conditions (2 major bands at ϳ25 and ϳ5 KDa; only the low molecular weight PLB is shown for PLBL lanes). Composite results are shown in Table 2 . Bottom: crude membranes prepared from rat and mouse LV were used to evaluate reactivity of polyclonal 11-13 antibody (1:500) against rat and mouse NCX1. To evaluate whether NCX1 density was similar between rat and mouse LV membranes, a monoclonal antibody (6H2; 1:1,000) raised against the NH2 terminus of NCX1 was used. Fig. 1 . Induced expression of Na ϩ /Ca 2ϩ exchanger transgene does not affect contractility response to isoproterenol in vivo. Doxycycline (Dox) was administered to all mice from gestation to day of experiment with the exception of induced (Ind) mice in which Dox was removed from the diet at 5 wk of age. Mice were studied at 8 to 10 wk of age. In vivo catheterization was performed in anesthetized mice, and maximal first time derivative of left ventricular pressure rise (ϩdP/dt) and fall (ϪdP/dt) and heart rate were continuously monitored, both at baseline and increasing doses of isoproterenol. To construct dose-response curve for isoproterenol, ϩdP/dt was normalized to the maximal value measured in each mouse. There are 7 wild-type (ᮀ), 7 induced (F), and 3 noninduced ({) mice. Error bars are not shown if they fall within the boundaries of the symbol. Composite results are shown in Table 1 .
Effects of induced NCX1 transgene expression on myocyte contraction. In all three groups of myocytes, elevating [Ca 2ϩ ] o resulted in the expected increase in contraction amplitudes (Fig. 4 and ] i transients in Ind myocytes may partly be due to changes in I Ca and its kinetics. In addition, in homozygous mice constitutively overexpressing NCX1 transgene, I Ca was significantly increased (27) , whereas in cardiacspecific NCX1 knockout mice, I Ca was substantially decreased compared with that of control WT mice (24) . Therefore, we measured I Ca in all three groups of myocytes. Our initial attempts to measure I Ca in FVB mouse myocytes using pipette and extracellular solutions previously designed for adult rat LV myocytes (43) and successfully applied to C57BL/6 mouse myocytes (37) were failures. For FVB mouse myocytes, we obtained consistent I Ca results after we adopted the pipette and bathing solutions published by Zhou et al. (47) and detailed in METHODS.
Maximal I Ca density and current-voltage relationships were not different among WT (Ϫ7.53 Ϯ 0.88 pA/pF; n ϭ 14), non-Ind (Ϫ7.38 Ϯ 0.91 pA/pF; n ϭ 9), and Ind (Ϫ7.25 Ϯ 0.32 pA/pF; n ϭ 11) myocytes (Fig. 6 ). The test potential at which maximal I Ca occurred was ϳ0 mV for all three groups of myocytes (Fig. 6 ). Neither the fast ( 1 ) nor the slow ( 2 ) inactivation time constant measured at 0 mV was significantly (P Ͻ 0.07) different in Ind ( 1 , 13.6 Ϯ 1.9 ms; and 2 , 49.3 Ϯ 6.6 ms) compared with WT ( 1 , 15.4 Ϯ 1.5 ms; and 2 , 72.7 Ϯ 7.7 ms) or non-Ind myocytes ( 1 , 13.7 Ϯ 1.5 ms; and 2 , 76.2 Ϯ 10.9 ms).
To further evaluate voltage-dependent properties of I Ca , steady-state inactivation of I Ca was determined using the classical two-pulse protocol (Fig. 7) . The sigmoidal relationships between the extent of inactivation (f ϱ ϭ I/I max ) and prepulse potential were superimposable for all three groups of myocytes (Fig. 7) . The test potential eliciting one-half maximal I Ca , V h , was not different among WT (Ϫ23.8 Ϯ 0.5 mV; n ϭ 8), non-Ind (Ϫ24.2 Ϯ 0.5 mV; n ϭ 6), and Ind (Ϫ23.9 Ϯ 0.5 mV; n ϭ 6) myocytes. Likewise, the slope factor k was similar among WT (5.1 Ϯ 0.4 mV), non-Ind (5.0 Ϯ 0.4 mV), and Ind (5.0 Ϯ 0.4 mV) myocytes.
Steady-state voltage dependence of I Ca activation (d ϱ ϭ I/I max ) was also similar among the three groups of myocytes Values are means Ϯ SE; numbers in parentheses are numbers of hearts used in crude membrane preparations. SERCA2, sarco(endo)plasmic reticulum Ca 2ϩ -ATPase; PLM, phospholemman; RyR2, cardiac ryanodine receptor; PLBH, high molecular weight phospholamban; PLBL, low molecular weight phospholamban. *P Ͻ 0.0005 compared with WT or Non-Ind. Since the 11-13 signal is 1.7ϫ stronger for mouse than rat NCX1 (Fig. 2 ), the corrected NCX1 protein level is ϳ2.54ϫ in Induced when compared with WT or Non-Ind myocytes. (Fig. 7) . V h was Ϫ20.2 Ϯ 1.8 mV, Ϫ18.2 Ϯ 2.1 mV, and Ϫ20.2 Ϯ 2.0 mV in WT (n ϭ 14), non-Ind (n ϭ 9), and Ind (n ϭ 11) myocytes, respectively. The slope factor k was 5.9 Ϯ 1.8 mV, 7.2 Ϯ 1.8 mV, and 7.0 Ϯ 1.8 mV in WT, non-Ind, and Ind myocytes, respectively. ] o was significantly (P Ͻ 0.03) higher in Ind compared with non-Ind myocytes ( Table 4 ). Given that I Ca is not affected by induced NCX1 overexpression (Figs. 6 and 7) , our findings suggest that NCX1 contributed directly to SR Ca 2ϩ loading. Effects of induced NCX1 transgene expression on action potential. Increased NCX1 activity may alter action potential morphology (2, 31) . We therefore measured action potential in WT, non-Ind, and Ind myocytes (Fig. 8) . When compared with that of WT myocytes, resting E m was significantly (P Ͻ 0.01) higher in non-Ind but not in Ind myocytes (Table 5 ). Action potential amplitude was lower in WT compared with either non-Ind (P Ͻ 0.008) or Ind (P Ͻ 0.035) myocytes. The most dramatic finding is the prolongation of action potential duration (APD) at 50% (APD 50 ) and 90% (APD 90 ) repolarization (P Ͻ 0.005) in Ind myocytes compared with either WT or non-Ind myocytes.
Effects of induced NCX1 transgene expression on SR
DISCUSSION
The first major finding is that we have engineered mice with inducible cardiac-specific expression of the rat cardiac NCX1. There are many similarities and some notable differences when comparing our current inducible mouse model with previously published mouse models that constitutively overexpress the canine NCX1 transgene (1, 27, 28, 36, 40) . For comparison purposes, we would focus mainly on the heterozygous (Het) mice constitutively overexpressing NCX1 transgene (1, 28, 36, 40) since our inducible mouse model is also heterozygous for the NCX1 transgene. We would also discuss relevant features of the homozygous (Hom) mice constitutively overexpressing the canine NCX1 transgene (27, 28) .
To achieve controlled expression of a transgene, investigators utilized a cardiac-specific promoter driving the expression of a tTA or of a reverse tTA in which four point mutations converted the system from a Tet-off (Dox is needed to keep transgene expression silent) to a Tet-on (transgene expression is active only in the presence of the drug) system (14) . Unfortunately, early experience with these systems was not favorable because of heterogeneous expression throughout the Table 3. ventricular and atrial cardiomyocyte populations, the potential for context-dependent expression because of the use of a virus-derived sequence, and leakiness or an inability to activate the gene in the presence or absence of Dox, respectively. The TREMHC vector we used allows robust expression when turned on in the absence of Dox and minimal leakage when turned off in the presence of Dox (29) . Minimal leakage is supported by the observation of similar I NaCa and NCX1 protein levels between WT and non-Ind myocytes, and inducible transgene expression is evidenced by increases in both I NaCa amplitude and NCX1 protein levels in Ind myocytes compared with WT or nonInd myocytes.
Similar to Het mice constitutively overexpressing NCX1 examined at 4 mo (28), mice with induced NCX1 overexpression (at 2 to 2.5 mo) had no differences in body weights, LV mass, heart rate, ejection fraction, fractional shortening, and baseline ϩdP/dt and ϪdP/dt compared with WT or non-Ind mice. The major difference between constitutive and induced NCX1 expression is that unlike HET mice constitutively overexpressing NCX1 that exhibited reduced contractility (ϩdP/dt) and relaxation (ϪdP/dt) in response to increasing doses of dobutamine compared with WT littermates (28), mice with induced NCX1 overexpression demonstrated similar inotropic and lusitropic responses to increasing doses of isoproterenol compared with WT or non-Ind controls. It is noteworthy that Hom mice constitutively overexpressing NCX1 developed cardiac hypertrophy, impaired LV fractional shortening, and markedly reduced contractility and relaxation in response to dobutamine compared with WT littermates (28). Table 4 .
Before comparing myocyte characteristics between Ind and Het mice, it is pertinent to point out that although myocytes were isolated from Ind mice at 8 to 10 wk of age, the ages of Het mice from which myocytes were derived were not specified (1, 36, 40) . At the myocyte level, Na ϩ -dependent Ca 2ϩ uptake in sarcolemmal vesicles isolated from adult Het mice constitutively overexpressing NCX1 is 148% (1) or 2.34ϫ (28) higher and I NaCa (at ϩ70 mV) is ϳ80% larger (36) compared with WT controls. Our results in myocytes with induced NCX1 expression are comparable in that the NCX1 protein was 2.5-fold higher and I NaCa was ϳ40% larger compared with WT or non-Ind myocytes. In an attempt to account for the differences between NCX1 protein expression and activity increase in Ind myocytes, we measured expression of PLM, which is a known endogenous inhibitor of NCX1 (7). Neither the expression level nor fractional phosphorylation of PLM was altered by induced NCX1 overexpression. The slight variability in increases in NCX1 activity between Ind and Het myocytes is most likely due to different techniques to estimate NCX1 activity and the conditions employed in measuring I NaCa . Similar to Het myocytes constitutively overexpressing NCX1 (28, 36) , there were no alterations in the expression of SERCA2, PLB, calsequestrin, and Na ϩ -K ϩ -ATPase in myocytes with induced NCX1 overexpression. Similar to Ind myocytes overexpressing rat NCX1, Het myocytes constitutively overexpressing canine NCX1 also had no differences in I Ca (1, 40) compared with WT myocytes.
In contrast with myocytes constitutively overexpressing NCX1 transgene in which absolute cell shortening magnitude (1.0 mM [Ca 2ϩ ] o and 0.5 Hz) was reported to be similar to that observed in WT myocytes (36), we found altered contractility in Ind myocytes depending on the prevailing [Ca 2ϩ ] o , which is known to be a relatively strong determinant of the exchanger equilibrium. At low [Ca 2ϩ ] o (conditions that promote Ca 2ϩ efflux), myocytes with induced NCX1 overexpression contracted less, whereas at high [Ca 2ϩ ] o (conditions that promote Ca 2ϩ influx), myocytes with induced NCX1 overexpression contracted more vigorously compared with their WT or nonInd controls. This increased dynamic range in response to increased [Ca 2ϩ ] o is characteristic of adult rat myocytes in which NCX1 was overexpressed by adenovirus-mediated gene transfer (45) and mouse myocytes in which NCX1 activity was increased by genetically eliminating PLM (37) . The results from these three fundamentally different approaches [in vitro NCX1 gene transfer (45) , induced NCX1 transgene expression in vivo (present study), and relief of NCX1 inhibition by PLM knockout (37) ] support our conclusion that alterations in NCX1 expression and/or activity can significantly impact myocyte contractile behavior.
Changes Fig. 6 . Induced expression of Na ϩ /Ca 2ϩ exchanger transgene has no effect on L-type Ca 2ϩ current (ICa) density. ICa was measured in WT (E; n ϭ 14), noninduced (ᮀ; n ϭ 9), and induced (F; n ϭ 11) myocytes at 30°C and 1. ]o and 30°C. Myocyte was held at Ϫ70 mV and switched to Ϫ40 mV immediately before prepulse (Ϫ30 to ϩ20 mV, 10-mV increments, 300 ms), after which myocyte was returned to Ϫ40 mV for 3 ms before test pulse (Ϫ40 to 0 mV, 300 ms). Bottom right: voltage dependence of inactivation (fϱ) of ICa in WT (E, red line; n ϭ 8), induced ({, green line; n ϭ 6), and noninduced (‚, blue line; n ϭ 6) myocytes. Composite data are presented in Table 5 . (9) . When field-stimulated to contract at 2 Hz, steady-state [Na ϩ ] i in PLM knockout myocytes is 17.0 Ϯ 1.5 mM and not significantly different than that measured in WT myocytes (15.2 Ϯ 1.5 mM) (11) . Since the increase in I NaCa is ϳ40% in Ind myocytes, comparable with the ϳ22% increase in PLM knockout myocytes (as compared with their respective controls), changes in [Na ϩ ] i due to moderately increased NCX1 activity, if any, would be small.
Another major finding is that when compared with non-Ind myocytes, both APD 50 and APD 90 were dramatically prolonged in Ind myocytes, despite no changes in resting E m and action potential amplitude. Prolongation of action potential was not due to changes in I Ca since neither the current density nor the inactivation time constants were affected by induced NCX1 transgene expression. Altered NCX1 activity may theoretically affect APD (2). In rat and mouse cardiac myocytes with short APD, there is a net Ca 2ϩ efflux via NCX1 at the shoulder of the action potential. This is because the action potential is already repolarizing before the [Ca 2ϩ ] i transient reaches its peak, and I NaCa is predominantly inward during this phase of the action potential (31) . Increase in NCX1 activity in Ind myocytes would therefore be expected to prolong APD, which is what we observed. In Het myocytes constitutively overexpressing NCX1, Yao et al. (40) reported decreased action potential amplitude and abbreviated APD 50 but prolonged APD 90 compared with WT myocytes. These authors hypothesized that decreased action potential amplitude and shortening of APD 50 were due to increased outward current secondary to enhanced reverse NCX1 (3 Na ϩ out and 1 Ca 2ϩ in) activity during early depolarization, whereas prolonged APD 90 was due to more marked forward NCX1 (3 Na ϩ in and 1 Ca 2ϩ out) activity during the [Ca 2ϩ ] i transient. The differences between our action potential findings in Ind myocytes and Het myocytes constitutively overexpressing NCX1 are not clear but may be due to different genetic backgrounds (FVB vs. C57Bl/6xC3H1), animal models (induced vs. constitutive), pipette solutions (Ca 2ϩ buffered vs. not buffered), temperature (30°vs. 25°C), and potential differences in other repolarizing currents such as transient outward current or other K ϩ currents. We do not know the reason for the observed differences in resting E m and action potential amplitude between WT and non-Ind myocytes. It is not due to Dox since it was administered to both WT and non-Ind mice from gestation up to the day of experiment.
In some, but not all, models of heart failure and hypertrophy, NCX1 expression has been reported to be increased (32) and hypothesized to be a major contributor to contractile dysfunction (19, 21) . In heart failure, expression of many proteins involved in cardiac Ca 2ϩ homeostasis such as SERCA2, PLB, RyR2, NCX1, etc., is known to be altered (8, 16) . Our current observations clearly indicated that induction of NCX1 overexpression in adult mice (to simulate switching on NCX1 expression with onset of disease state), without concomitant changes in other proteins involved in Ca 2ϩ transport, did not result in contractile dysfunction in vivo. In this light, it is interesting to note that NCX1 has been shown to significantly contribute to the maintenance of contractile function and [Ca 2ϩ ] i transients in failing human ventricular myocytes (12, 15) . Our novel model of inducible NCX1 transgenic expression is eminently suited for studies to dissect whether overexpression of NCX1 found in heart failure models is beneficial or harmful to the animal.
In summary, we have generated a novel mouse model in which cardiac-specific expression of rat NCX1 can be controlled. Despite no detectable differences in cardiac performance in vivo, LV myocytes with induced expression of NCX1 transgene exhibited prolonged APD, enhanced contractility, [Ca 2ϩ ] i transient amplitude, and SR Ca 2ϩ content at high [Ca 2ϩ ] o , but no changes in I Ca , SERCA2, RyR2, PLB, Na ϩ -K ϩ -ATPase, phospholemman, calsequestrin, and SR Ca 2ϩ uptake. We conclude that NCX1 operates in both forward and reverse modes during an action potential, directly contributes to SR Ca 2ϩ filling, and regulates myocyte contractility. In addition, induced NCX1 transgene expression at levels found in diseased hearts, by itself, was not associated with cardiac dysfunction in young adult mice.
